cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.6139052.v1
title: Experimental Results for Sound Value Iteration

description: This file contains the experimental results for the paper<br>"Sound Value Iteration"<br>by Tim Quatmann and Joost-Pieter Katoen presented at CAV 2018.<br><br>- The directory ./models contains all model files (in the PRISM input language) and the corresponding properties that were considered in the paper.<br>- The directory ./logs/ contains all obtained logfiles, i.e., the output generated by Storm and Prism, respectively.<br>- The file ./data.csv lists model checking times and the number of performed iterations as extracted from the logfiles.
DOI: 10.6084/m9.figshare.6139028
title: Seasonality, habitat type and locality influenced bird assemblage structure in Nigeria

description: This is the first report of the avian assemblage in the study area of Dutse, Nigeria. In addition to recording bird species, the effects of season, dominant vegetation structure, locality and anthropogenic activities on bird abundance, species richness and diversity were investigated. Using the point transect method, 264 points on 48 km of transect were used to count birds between 06:30 and 11:00 from August 2015 to February 2016. A total of 122 bird species of 41 families were recorded. Highest bird species richness was recorded in Warwade, highest abundance in Model, and highest diversity in Malamawa. The dry season and woodland habitat showed higher bird species richness, abundance and diversity than the wet season and shrubland habitat. Tree density was more important in increasing bird abundance than shrub density. Small-scale anthropogenic activities and habitat modification, such as farming, grazing, wood removal and human interference did not appear to have impacted the birds; however, loss of high tree-density woodland habitats may pose a major threat to the bird community in Dutse. The presence of birds of concern in the area suggests the need for conservation efforts of avifauna and as well as the forested habitats in Dutse.
DOI: 10.6084/m9.figshare.6139028.v2
title: Seasonality, habitat type and locality influenced bird assemblage structure in Nigeria

description: This is the first report of the avian assemblage in the study area of Dutse, Nigeria. In addition to recording bird species, the effects of season, dominant vegetation structure, locality and anthropogenic activities on bird abundance, species richness and diversity were investigated. Using the point transect method, 264 points on 48 km of transect were used to count birds between 06:30 and 11:00 from August 2015 to February 2016. A total of 122 bird species of 41 families were recorded. Highest bird species richness was recorded in Warwade, highest abundance in Model, and highest diversity in Malamawa. The dry season and woodland habitat showed higher bird species richness, abundance and diversity than the wet season and shrubland habitat. Tree density was more important in increasing bird abundance than shrub density. Small-scale anthropogenic activities and habitat modification, such as farming, grazing, wood removal and human interference did not appear to have impacted the birds; however, loss of high tree-density woodland habitats may pose a major threat to the bird community in Dutse. The presence of birds of concern in the area suggests the need for conservation efforts of avifauna and as well as the forested habitats in Dutse.
DOI: 10.6084/m9.figshare.6139028.v1
title: Seasonality, habitat type and locality influenced bird assemblage structure in Nigeria

description: This is the first report of the avian assemblage in the study area of Dutse, Nigeria. In addition to recording bird species, the effects of season, dominant vegetation structure, locality and anthropogenic activities on bird abundance, species richness and diversity were investigated. Using the point transect method, 264 points on 48 km of transect were used to count birds between 06:30 and 11:00 from August 2015 to February 2016. A total of 122 bird species of 41 families were recorded. Highest bird species richness was recorded in Warwade, highest abundance in Model, and highest diversity in Malamawa. The dry season and woodland habitat showed higher bird species richness, abundance and diversity than the wet season and shrubland habitat. Tree density was more important in increasing bird abundance than shrub density. Small-scale anthropogenic activities and habitat modification, such as farming, grazing, wood removal and human interference did not appear to have impacted the birds; however, loss of high tree-density woodland habitats may pose a major threat to the bird community in Dutse. The presence of birds of concern in the area suggests the need for conservation efforts of avifauna and as well as the forested habitats in Dutse.
DOI: 10.6084/m9.figshare.6139025
title: Supplementary Material for: C-Reactive Protein and Procalcitonin in Case Reports of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome

description: <b><i>Background:</i></b> The spectrum of inflammatory marker response in DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome has not been systematically characterized. <b><i>Methods:</i></b> An epidemiological biomarker study of C-reactive protein (CRP) and procalcitonin (PCT) values in patients with DRESS syndrome reported at 2 regional pharmacovigilance centers in Switzerland or published in the medical literature 2008–2016 was performed. <b><i>Results:</i></b> Ninety-four DRESS cases were studied. All cases showed a CRP value &gt; 10 mg/L (the upper limit of normal). The mean CRP value was 109.2 ± 79.4 mg/L. CRP values were significantly higher in 22 cases where a cause of inflammation besides DRESS could not be excluded (mean 162.1 vs. 92.9 mg/L; <i>p</i> = 0.003). Receiver operator characteristics curve analysis showed a moderate performance with a CRP cut-off value of 99.4 mg/L (AUC 0.717) to distinguish between patients with and without a possible additional cause of inflammation. The mean and median PCT values were 2.44 ± 5.94 and 0.69 ng/mL, respectively (<i>n</i> = 25 patients). Patients in whom an additional cause of inflammation besides DRESS could not be excluded showed a median PCT of 1.37 ng/mL (<i>n</i> = 9) versus 0.67 ng/mL (<i>n</i> = 16) in patients with DRESS only. PCT values were above the normal cut-off of 0.1 ng/mL, suggestive of bacterial infection in all but 1 case. Furthermore, there was a correlation between PCT values and hepatic enzyme measurements. <b><i>Conclusions:</i></b> Evaluating CRP and PCT values might be of use in helping physicians to distinguish between cases of DRESS syndrome with and without concurrent infection or other causes of inflammation. Further prospective investigation is required to define the use of these inflammatory markers in the management of DRESS.
DOI: 10.6084/m9.figshare.6138986
title: Neutron reflectivity with the Multi-blade detector

description: The data refers to the measurements performed on the CRISP neutron reflectometer at ISIS with the Multi-Blade detector. The data for the direct beam and three samples: Iridium, Silicon and Fe/Si supermirror, are reported. The raw data from the read-out electronics is reduced to a matrix structure (X,Y,T,λ) which identifies a single neutron event. X and Y are the spatial coordinates of the strips and wires, respectively, in the detector. T is the time of flight of the neutron that reach the detector, while λ is the associated neutron wavelength determined by the time and geometry of the instrument. The data are collected for each digitizer, six in total, and each one corresponds to a cassette of the detector.The specular reflectivity measurement on the Iridium sample were performed tilting the sample position in step of 0.1 degree in the 0.2-0.8 degrees range.The specular reflectivity measurement on the Silicon sample were performed using both a collimated and divergent beam, at three and four angle respectively: 0.2, 0.3 and 0.8 degrees in the former configuration and 0.2, 0.3, 0.8 and 1.2 degrees in the latter configuration.The off-specular measurement on the Fe/Si supermirror sample were performed tilting the sample position in step of 0.01 degree in the 0.2-0.8 degrees range.The analyzed data for the Iridium and Silicon sample are reduced in (qz, R), where qz is the wave vector transfer and R is the reflected intensity, using the conventional analysis and the θ-corrected reduction. The latter is applied considering both the spatial resolution of the Multi-Blade detector (~0.6 mm) and the state-of-art detectors spatial resolution (~2 mm). The off-speculardata are reduced to a matrix structure (pi, pf, I, pi-pf, pi+pf) where pi and pf are the projections of the initial and final wave vectors, obtained encoding the neutron wavelengths and the incident and reflected angles and I represents the reflected intensity.The available scripts allow to reduce the initial matrix data (X,Y,T,λ) into the (qz, R) for the Iridium and Silicon sample and (pi, pf, I, pi-pf, pi+pf) for the Fe/Si sample and to plot the final results.
DOI: 10.6084/m9.figshare.6138986.v1
title: Neutron reflectivity with the Multi-blade detector

description: The data refers to the measurements performed on the CRISP neutron reflectometer at ISIS with the Multi-Blade detector. The data for the direct beam and three samples: Iridium, Silicon and Fe/Si supermirror, are reported. The raw data from the read-out electronics is reduced to a matrix structure (X,Y,T,λ) which identifies a single neutron event. X and Y are the spatial coordinates of the strips and wires, respectively, in the detector. T is the time of flight of the neutron that reach the detector, while λ is the associated neutron wavelength determined by the time and geometry of the instrument. The data are collected for each digitizer, six in total, and each one corresponds to a cassette of the detector.The specular reflectivity measurement on the Iridium sample were performed tilting the sample position in step of 0.1 degree in the 0.2-0.8 degrees range.The specular reflectivity measurement on the Silicon sample were performed using both a collimated and divergent beam, at three and four angle respectively: 0.2, 0.3 and 0.8 degrees in the former configuration and 0.2, 0.3, 0.8 and 1.2 degrees in the latter configuration.The off-specular measurement on the Fe/Si supermirror sample were performed tilting the sample position in step of 0.01 degree in the 0.2-0.8 degrees range.The analyzed data for the Iridium and Silicon sample are reduced in (qz, R), where qz is the wave vector transfer and R is the reflected intensity, using the conventional analysis and the θ-corrected reduction. The latter is applied considering both the spatial resolution of the Multi-Blade detector (~0.6 mm) and the state-of-art detectors spatial resolution (~2 mm). The off-speculardata are reduced to a matrix structure (pi, pf, I, pi-pf, pi+pf) where pi and pf are the projections of the initial and final wave vectors, obtained encoding the neutron wavelengths and the incident and reflected angles and I represents the reflected intensity.The available scripts allow to reduce the initial matrix data (X,Y,T,λ) into the (qz, R) for the Iridium and Silicon sample and (pi, pf, I, pi-pf, pi+pf) for the Fe/Si sample and to plot the final results.
DOI: 10.6084/m9.figshare.6138980
title: Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T)

description: <b>Objective:</b> To evaluate the efficacy and safety of sirukumab, a human anti-interleukin six monoclonal antibody, in Japanese patients with rheumatoid arthritis who were refractory to anti-tumor necrosis factor therapy. <b>Methods:</b> This subgroup analysis, based on a double-blind, placebo-controlled, 52-week phase 3, global study (SIRROUND-T) assessed the American College of Rheumatology (ACR) 20 response at week 16 (primary endpoint). Secondary endpoints: ACR 50, Disease Activity Score in 28 joints-C reactive protein, Health Assessment Questionnaire-Disability Index and safety were assessed. <b>Results</b> 116/878 patients received sirukumab 50 mg/4 weeks (q4w, <i>n</i> = 35), 100 mg/2 weeks (q2w, <i>n</i> = 44) or placebo (<i>n</i> = 37) subcutaneously. Significantly more patients achieved ACR 20 response at week 16 with sirukumab (50 mg q4w:20 [57.1%]; <i>p</i> p = .001) versus placebo (7 [18.9%]); consistent significant improvement in secondary endpoints at week 24 and 52 was observed. At week 24, incidence of treatment-emergent adverse events (TEAEs) was numerically higher with sirukumab groups (50 mg q4w:29 [82.9%]; 100 mg q2w:38 [86.4%] versus placebo (28 [75.7%]); however, at week 52, sirukumab combined groups had comparable incidence of TEAEs. <b>Conclusion:</b> Efficacy findings through 52 weeks were comparable between sirukumab doses in Japanese patients and consistent with primary SIRROUND-T study results. No new safety signals were observed.
DOI: 10.6084/m9.figshare.6138980.v1
title: Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T)

description: <b>Objective:</b> To evaluate the efficacy and safety of sirukumab, a human anti-interleukin six monoclonal antibody, in Japanese patients with rheumatoid arthritis who were refractory to anti-tumor necrosis factor therapy. <b>Methods:</b> This subgroup analysis, based on a double-blind, placebo-controlled, 52-week phase 3, global study (SIRROUND-T) assessed the American College of Rheumatology (ACR) 20 response at week 16 (primary endpoint). Secondary endpoints: ACR 50, Disease Activity Score in 28 joints-C reactive protein, Health Assessment Questionnaire-Disability Index and safety were assessed. <b>Results</b> 116/878 patients received sirukumab 50 mg/4 weeks (q4w, <i>n</i> = 35), 100 mg/2 weeks (q2w, <i>n</i> = 44) or placebo (<i>n</i> = 37) subcutaneously. Significantly more patients achieved ACR 20 response at week 16 with sirukumab (50 mg q4w:20 [57.1%]; <i>p</i> p = .001) versus placebo (7 [18.9%]); consistent significant improvement in secondary endpoints at week 24 and 52 was observed. At week 24, incidence of treatment-emergent adverse events (TEAEs) was numerically higher with sirukumab groups (50 mg q4w:29 [82.9%]; 100 mg q2w:38 [86.4%] versus placebo (28 [75.7%]); however, at week 52, sirukumab combined groups had comparable incidence of TEAEs. <b>Conclusion:</b> Efficacy findings through 52 weeks were comparable between sirukumab doses in Japanese patients and consistent with primary SIRROUND-T study results. No new safety signals were observed.
DOI: 10.6084/m9.figshare.6138977
title: Supplementary Material for: Sociocultural and Familial Factors Associated with Weight Bias Internalization

description: <b><i>Background/Aims:</i></b> Sociocultural and familial factors associated with weight bias internalization (WBI) are currently unknown. The present study explored the relationship between interpersonal sources of weight stigma, family weight history, and WBI. <b><i>Methods:</i></b> Participants with obesity (N = 178, 87.6% female, 71.3% black) completed questionnaires that assessed the frequency with which they experienced weight stigma from various interpersonal sources. Participants also reported the weight status of their family members and completed measures of WBI, depression, and demographics. Participant height and weight were measured to calculate body mass index (BMI). <b><i>Results:</i></b> Linear regression results (controlling for demographics, BMI, and depression) showed that stigmatizing experiences from family and work predicted greater WBI. Experiencing weight stigma at work was associated with WBI above and beyond the effects of other sources of stigma. Participants who reported higher BMIs for their mothers had lower levels of WBI. <b><i>Conclusion:</i></b> Experiencing weight stigma from family and at work may heighten WBI, while having a mother with a higher BMI may be a protective factor against WBI. Prospective research is needed to understand WBI's developmental course and identify mechanisms that increase or mitigate its risk.
DOI: 10.6084/m9.figshare.6138956
title: Supplementary Material for: Respiratory Management of Extremely Preterm Infants: An International Survey

description: <b><i>Background:</i></b> There are significant international variations in chronic lung disease rates among very preterm infants yet there is little data on international variations in respiratory strategies. <b><i>Objective:</i></b> To evaluate practice variations in the respiratory management of extremely preterm infants born at &lt; 29 weeks’ gestational age (GA) among 10 neonatal networks participating in the International Network for Evaluating Outcomes (iNeo) of Neonates collaboration. <b><i>Methods:</i></b> A web-based survey was sent to the representatives of 390 neonatal intensive care units from Australia/New Zealand, Canada, Finland, Illinois (USA), Israel, Japan, Spain, Sweden, Switzerland, and Tuscany (Italy). Responses were based on practices in 2015. <b><i>Results:</i></b> Overall, 321 of the 390 units responded (82%). The majority of units within networks (40–92%) mechanically ventilate infants born at 23–24 weeks’ GA on continuous positive airway pressure (CPAP) with 30–39% oxygen in respiratory distress within 48 h after birth, but the proportion of units that offer mechanical ventilation for infants born at 25–26 weeks’ GA at similar settings varied significantly (20–85% of units within networks). The most common respiratory strategy for infants born at 27–28 weeks’ GA on CPAP with 30–39% oxygen with respiratory distress within 48 h after birth used by units also varied significantly among networks: mechanical ventilation (0–60%), CPAP (3–82%), intubation and surfactant administration with immediate extubation (0–75%), and less invasive surfactant administration (0–68%). <b><i>Conclusions:</i></b> There are marked variations but also similarities in respiratory management of extremely preterm infants between networks. Further collaboration and exploration is needed to better understand the association of these variations in practice with pulmonary outcomes.
DOI: 10.6084/m9.figshare.6138956.v1
title: Supplementary Material for: Respiratory Management of Extremely Preterm Infants: An International Survey

description: <b><i>Background:</i></b> There are significant international variations in chronic lung disease rates among very preterm infants yet there is little data on international variations in respiratory strategies. <b><i>Objective:</i></b> To evaluate practice variations in the respiratory management of extremely preterm infants born at &lt; 29 weeks’ gestational age (GA) among 10 neonatal networks participating in the International Network for Evaluating Outcomes (iNeo) of Neonates collaboration. <b><i>Methods:</i></b> A web-based survey was sent to the representatives of 390 neonatal intensive care units from Australia/New Zealand, Canada, Finland, Illinois (USA), Israel, Japan, Spain, Sweden, Switzerland, and Tuscany (Italy). Responses were based on practices in 2015. <b><i>Results:</i></b> Overall, 321 of the 390 units responded (82%). The majority of units within networks (40–92%) mechanically ventilate infants born at 23–24 weeks’ GA on continuous positive airway pressure (CPAP) with 30–39% oxygen in respiratory distress within 48 h after birth, but the proportion of units that offer mechanical ventilation for infants born at 25–26 weeks’ GA at similar settings varied significantly (20–85% of units within networks). The most common respiratory strategy for infants born at 27–28 weeks’ GA on CPAP with 30–39% oxygen with respiratory distress within 48 h after birth used by units also varied significantly among networks: mechanical ventilation (0–60%), CPAP (3–82%), intubation and surfactant administration with immediate extubation (0–75%), and less invasive surfactant administration (0–68%). <b><i>Conclusions:</i></b> There are marked variations but also similarities in respiratory management of extremely preterm infants between networks. Further collaboration and exploration is needed to better understand the association of these variations in practice with pulmonary outcomes.
DOI: 10.6084/m9.figshare.6138947
title: Figure 7G raw data

description: Raw data of figure 7G: Sizes of lysis plaques for invasion level measurement.
DOI: 10.6084/m9.figshare.6138947.v1
title: Figure 7G raw data

description: Raw data of figure 7G: Sizes of lysis plaques for invasion level measurement.
DOI: 10.6084/m9.figshare.6138944
title: Fig 7EF raw data

description: Raw data of figure 7EF: Plaque assays of plant-derived IgG antibodies, compared with NC.
DOI: 10.6084/m9.figshare.6138944.v1
title: Fig 7EF raw data

description: Raw data of figure 7EF: Plaque assays of plant-derived IgG antibodies, compared with NC.
DOI: 10.6084/m9.figshare.6138941
title: Fig 7C raw data

description: Raw data of figure 7C: Invasion assay of chimeric IgGs tested and NC.
DOI: 10.6084/m9.figshare.6138941.v1
title: Fig 7C raw data

description: Raw data of figure 7C: Invasion assay of chimeric IgGs tested and NC.
DOI: 10.6084/m9.figshare.6138935
title: Fig 7D raw data

description: Raw data of figure 7D: attachment assays of chimeric IgGs and NC.
DOI: 10.6084/m9.figshare.6138935.v1
title: Fig 7D raw data

description: Raw data of figure 7D: attachment assays of chimeric IgGs and NC.
DOI: 10.6084/m9.figshare.6138932
title: Fig 7AB raw data

description: Raw data of figure 7AB: Invasive efficacy of NC and IgG-treated parasites.
DOI: 10.6084/m9.figshare.6138932.v1
title: Fig 7AB raw data

description: Raw data of figure 7AB: Invasive efficacy of NC and IgG-treated parasites.
DOI: 10.6084/m9.figshare.6138929
title: Fig 6 raw data - TG130

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - TG130.
DOI: 10.6084/m9.figshare.6138929.v1
title: Fig 6 raw data - TG130

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - TG130.
DOI: 10.6084/m9.figshare.6138926
title: Fig 6 raw data - RT51

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - RT51.
DOI: 10.6084/m9.figshare.6138926.v1
title: Fig 6 raw data - RT51

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - RT51.
DOI: 10.6084/m9.figshare.6138923
title: Fig 6 raw data - RS55

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - RS55.
DOI: 10.6084/m9.figshare.6138923.v1
title: Fig 6 raw data - RS55

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - RS55.
DOI: 10.6084/m9.figshare.6138920
title: Fig 6 raw data - RA15

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - RA15.
DOI: 10.6084/m9.figshare.6138920.v1
title: Fig 6 raw data - RA15

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - RA15.
DOI: 10.6084/m9.figshare.6138917
title: Fig 6 raw data - NC

description: Immunofluorescence assays for the detection of extracellular parasites by buffer control - NC.
DOI: 10.6084/m9.figshare.6138917.v1
title: Fig 6 raw data - NC

description: Immunofluorescence assays for the detection of extracellular parasites by buffer control - NC.
DOI: 10.6084/m9.figshare.6138914
title: Fig 6 raw data - LT3

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - LT3.
DOI: 10.6084/m9.figshare.6138914.v1
title: Fig 6 raw data - LT3

description: Immunofluorescence assays for the detection of extracellular parasites by chimeric antibody - LT3.
DOI: 10.6084/m9.figshare.6138905
title: Fig 5 raw data

description: Raw data of figure 5: Immunoblot analysis of chimeric <i>T. gondii</i>-specific IgGs.